<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Postmarketing Approaches To Obtain Data on Under-Represented Populations in Clinical Trials; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Postmarketing Approaches To Obtain Data on Under-Represented Populations in Clinical Trials; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-08-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Postmarketing Approaches to Obtain Data on Under-Represented Populations in Clinical Trials." The purpose of this draft guidance is to describe FDA requirements and provide recommendations for obtaining safety and effectiveness information on drug and biological products, when appropriate, in the postmarketing setting in historically under- represented patient populations in...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-17267</p>
    <p><strong>Publication Date:</strong> 2023-08-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/08/11/2023-17267/postmarketing-approaches-to-obtain-data-on-under-represented-populations-in-clinical-trials-draft">https://www.federalregister.gov/documents/2023/08/11/2023-17267/postmarketing-approaches-to-obtain-data-on-under-represented-populations-in-clinical-trials-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-17267</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
